Workflow
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
Globenewswire· 2026-01-14 02:00
Core Viewpoint - BriaCell Therapeutics Corp. has announced a public offering of 5,366,726 units at a price of $5.59 per unit, aiming to raise approximately $30 million before expenses [1][2]. Group 1: Offering Details - Each unit consists of one common share (or a pre-funded warrant) and one warrant, with the warrants approved for listing on the Nasdaq Capital Market under the symbol "BCTXL" [1]. - The warrants are immediately exercisable at an exercise price of $6.93 per share and will expire five years from issuance [1]. - The offering is expected to close on January 15, 2026, subject to customary closing conditions [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to fund working capital requirements, general corporate purposes, and to advance the company's business objectives [3]. Group 3: Regulatory Information - A registration statement related to the securities was filed with the SEC on December 23, 2025, and became effective on January 13, 2026 [4]. - The offering is being made only by means of a prospectus, with copies available from ThinkEquity and on the SEC's website [4]. Group 4: Company Overview - BriaCell is a clinical-stage biotechnology company focused on developing novel immunotherapies to transform cancer care [6].
Fujifilm Introduces instax mini Link+™ Smartphone Printer
Businesswire· 2026-01-14 02:00
Core Insights - FUJIFILM North America Corporation has launched the instax mini Link+ smartphone printer, enhancing its product lineup with new features aimed at creativity and user engagement [1] Product Features - The instax mini Link+ integrates advanced instant photo technology into the existing instax mini Link smartphone app, offering new and improved print modes [1] - The new features focus on inspiration, impact, and imagination, catering to a broader range of user needs and preferences [1]
Lights, Evo, Action: Fujifilm Introduces instax mini Evo Cinema™ Hybrid Instant Camera
Businesswire· 2026-01-14 02:00
Core Viewpoint - FUJIFILM North America Corporation has launched the instax mini Evo Cinema hybrid instant camera, which allows users to create personalized content through various formats including still photos, short-form videos, and instant prints [1] Product Features - The instax mini Evo Cinema is a 3-in-1 camera that combines still photography, 15-second video clips, and instax mini photo prints [1] - Users can enhance their experience by utilizing the free, downloadable instax mini Evo smartphone app [1]
Wall Street falls with financials amid credit card rate plan concern
The Economic Times· 2026-01-14 01:55
Helping to limit the day's decline, a report early in the day showed ‌that a reading ‌on U.S. inflation for December came in as expected, leaving intact market expectations for Shares of Visa fell 4.5%, Mastercard dropped 3.8% and the financial sector fell 1.8%, leading declines in the S&P 500. Shares of JPMorgan ended down 4.2%. The bank reported a better-than-expected quarterly profit but also a drop in investment banking fees. "Financials are getting hit by Trump's credit-card proposal," said Tim ‌Ghri ...
AI: Short Circuit?
Seeking Alpha· 2026-01-14 01:50
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]
Exxon Baton Rouge, Louisiana refinery preparing to run Venezuelan oil, sources say
Reuters· 2026-01-14 01:48
Core Insights - Exxon Mobil is preparing to process Venezuelan crude oil at its Baton Rouge refinery in Louisiana [1] Company Operations - The Baton Rouge refinery is set to begin operations with Venezuelan crude oil, indicating a strategic move by Exxon Mobil to diversify its crude supply sources [1]
BBWI Investors Have Opportunity to Lead Bath & Body Works, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Businesswire· 2026-01-14 01:48
Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. for alleged violations of securities laws, claiming the company made false and misleading statements that negatively impacted investors [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against the Company - The complaint alleges that Bath & Body Works made false and misleading statements regarding its business strategy, which included seeking "adjacencies, collaborations and promotions" that failed to grow its customer base and net sales [4]. - The company reportedly relied on brand collaborations to "carry quarters" despite experiencing weak financial results, leading to misleading public statements throughout the class period [4]. - Investors suffered damages when the truth about the company's performance was revealed [4].
Trump Administration Enacts Security Rules for Nvidia's China Chip Sales
WSJ· 2026-01-14 01:46
Core Viewpoint - The chip designer and its customers are required to meet specific security requirements prior to the approval of exports [1] Group 1 - The necessity for compliance with security requirements is emphasized for both the chip designer and its customers [1]
American Express Stock Dips. Time to Buy?
The Motley Fool· 2026-01-14 01:41
A policy headline spooked credit card investors. Is this a buying opportunity?Credit card stocks and shares of banks that lend to credit card users took a hit on Monday after President Donald Trump discussed plans to cap credit card interest rates. Shares of American Express (AXP 0.44%) declined approximately 4% on Monday, and the stock continued to fall (albeit only slightly) on Tuesday.It's easy to see why the market reacted negatively to the news. Credit card interest rates are a major part of the econom ...
Fiduciary Management Q4 2025 Investment Strategy Outlook
Seeking Alpha· 2026-01-14 01:40
Galeanu Mihai/iStock via Getty Images The intoxication with Artificial Intelligence (AI) related companies continued in 2025, in conjunction with a low-quality “junk” rally that added fuel to the fire. Investors who were willing to extend out along the risk curve were rewarded. The Russell 2000 (RUT), S&P 500 (SP500), Msci Eafe (Local/USD), and MSCI World (MSCI WORLD) gained 12.81%, 17.88%, 20.60%/31.22%, and 21.09%, respectively. Many Wall Street strategists are now penciling in greater than 10% return ...